NM_001377265.1:c.-18+19220A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001377265.1(MAPT):​c.-18+19220A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.143 in 152,126 control chromosomes in the GnomAD database, including 2,130 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 2130 hom., cov: 32)

Consequence

MAPT
NM_001377265.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.278

Publications

51 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001377265.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
NM_001377265.1
MANE Select
c.-18+19220A>G
intron
N/ANP_001364194.1
MAPT
NM_001123066.4
c.-18+19220A>G
intron
N/ANP_001116538.2
MAPT
NM_016835.5
c.-18+19220A>G
intron
N/ANP_058519.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPT
ENST00000262410.10
TSL:1 MANE Select
c.-18+19220A>G
intron
N/AENSP00000262410.6
MAPT
ENST00000344290.10
TSL:1
c.-18+19220A>G
intron
N/AENSP00000340820.6
MAPT
ENST00000351559.10
TSL:1
c.-18+19220A>G
intron
N/AENSP00000303214.7

Frequencies

GnomAD3 genomes
AF:
0.143
AC:
21810
AN:
152008
Hom.:
2132
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0431
Gnomad AMI
AF:
0.278
Gnomad AMR
AF:
0.175
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.0742
Gnomad FIN
AF:
0.0645
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.185
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.143
AC:
21800
AN:
152126
Hom.:
2130
Cov.:
32
AF XY:
0.134
AC XY:
9980
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.0430
AC:
1787
AN:
41524
American (AMR)
AF:
0.175
AC:
2671
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.240
AC:
834
AN:
3470
East Asian (EAS)
AF:
0.00213
AC:
11
AN:
5176
South Asian (SAS)
AF:
0.0743
AC:
358
AN:
4820
European-Finnish (FIN)
AF:
0.0645
AC:
684
AN:
10600
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.217
AC:
14755
AN:
67966
Other (OTH)
AF:
0.182
AC:
384
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
916
1833
2749
3666
4582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
2394
Bravo
AF:
0.148
Asia WGS
AF:
0.0310
AC:
109
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.3
DANN
Benign
0.51
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17563986; hg19: chr17-43991272; API